E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/4/2009 in the Prospect News Special Situations Daily.

Natus Medical shareholder D3 sells shares, keeps 12.9% interest

By Lisa Kerner

Charlotte, N.C., May 4 - Natus Medical Inc. investors led by D3 Family Fund, LP sold 731,254 shares of the company's stock between March 16 and April 30 priced from $7.62 to $8.90 each.

The transactions were reported in a schedule 13D/A filed on Monday with the Securities and Exchange Commission.

D3 beneficially owns 3,602,044 shares, or 12.9%, of the San Carlos, Calif.-based manufacturer of neurondiagnostic and newborn care products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.